Skip to main content
. 2015 Apr 3:407–435.e18. doi: 10.1016/B978-1-4557-3383-5.00025-7

Table 25-5.

Patterns of Abnormal Function for Various Pulmonary Disorders

Emphysema Chronic Bronchitis COPD Asthma RESTRICTION

Test Parenchymal Chest Wall Neuromuscular PVO CHF
FVC (L) (N)⇒ ↓ (N)⇒ ↓ (N)⇒ ↓ (N)⇒ ↓ N⇒ ↓ N
FEV1 (L) N⇒ ↓ N
FEV1/FVC (%) N⇒ ↓ N⇒↑ N N N N⇒ ↓
FEF (L/sec) N⇒ ↓ N⇒ ↓ N
PEF (L/sec) N⇒ ↓ N⇒ ↓ N
MVV (L/min) N⇒ ↓ N⇒ ↓ N
FEF50 (L/sec) N⇒ ↓ N⇒ ↓ N
TLC (L) N⇒↑ N⇒↑ N⇒ ↓ N⇒↓*
RV (L) N⇒↑ N ↑⇒N⇒ ↓
RV/TLC (%) N N⇒↑ N⇒↑ N ↑⇒N⇒ ↓
DlCO (mL/min/mm Hg) N⇒↓ N⇒↓ ↑⇒N N⇒↓ N⇒↓ ↓⇒N⇒↑
Pao2 (mm Hg) N⇒↓ N⇒↓ N⇒↓ N N⇒↓ N⇒↓ N⇒↓
Sao2 (%) N⇒↓ N⇒↓ N⇒↓ N N⇒↓ N⇒↓ N⇒↓
Paco2 (mm Hg) N⇒↑ N⇒↑ N⇒↓ N⇒↓ N N⇒↑ N⇒↓
pH (−log[H+]) N⇒↓ N⇒↓ N⇒↓ N⇒↑ N⇒↑ N N⇒↓ N N⇒↑
Raw (cm H2O/L/sec) ↓⇒N⇒↑ N⇒↑ N⇒↑ N N⇒↑
CstL (L/cm H2O) N N⇒↑ N⇒↑ N N N N⇒↓
CdynL (L/cm H2O) N⇒↓ N⇒↓ N⇒↓ N N N N ⇒↓
Pstmax (cm H2O) N N⇒↓ N⇒↑ N⇒↓ N⇒↓ N N⇒↓
Phase III (% N2/L) N⇒↑ N N N N⇒↑
Phase IV (% VC) A ↑⇒A ↑⇒A ↑⇒A N⇒↑ N N N N⇒↑
MEP (cm H2O) N⇒↓ ↓⇒N⇒↑ N N⇒↓ N⇒↓ ↓↓ N N
MIP (cm H2O) N N⇒↓ N N⇒↑ N⇒↑ ↓↓ N N

A, often absent; N, normal; (N), occasionally normal; ⇒, to; ↑, increased; ↓, decreased. CdynL, dynamic compliance of the lung; CHF, congestive heart failure; CstL, static compliance of the lung; DlCO, diffusing capacity of the lung for carbon monoxide; Dl/Va, diffusing capacity of the lung/alveolar volume; FEF, forced expiratory flow; FEF50, forced expiratory flow after 50% of vital capacity exhaled; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; MVV, maximal voluntary ventilation; Paco2, arterial Pco2; Pao2, arterial Po2; PEF, peak expiratory flow; Pstmax, maximal static pressure; PVO, pulmonary vascular obstruction; Raw, airway resistance; RV, residual volume; Sao2, arterial oxygen saturation; TLC, total lung capacity.

*

Volumes are decreased in the presence of primary pulmonary hypertension but not chronic thromboemboli.